Yekaterina Chudnovsky
Director/Board Member at ELICIO THERAPEUTICS, INC.
Net worth: 10 M $ as of 30/03/2024
Profile
Yekaterina Chudnovsky is currently the Chairman at Gi Research Foundation, Director at Elicio Therapeutics, Inc. (United States), Director at xCures, Inc., Independent Director at Immix Biopharma, Inc., Independent Director at Elicio Therapeutics, Inc., and Director at Gkcc LLC.
She has an undergraduate degree from Northwestern University and a graduate degree from DePaul University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMIX BIOPHARMA, INC.
12.69% | 21/08/2023 | 3,241,076 ( 12.69% ) | 10 M $ | 30/03/2024 |
ELICIO THERAPEUTICS, INC
-.--% | 18/03/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Yekaterina Chudnovsky active positions
| Companies | Position | Start |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director/Board Member | 30/09/2022 |
| IMMIX BIOPHARMA, INC. | Director/Board Member | 21/08/2023 |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Director/Board Member | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Director/Board Member | - |
| Gkcc LLC | Director/Board Member | - |
Training of Yekaterina Chudnovsky
| Northwestern University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |
| Immix Biopharma, Inc. | |
| Gkcc LLC |
- Stock Market
- Insiders
- Yekaterina Chudnovsky
